# Polyethylene Glycol (PEG) Versus Sennosides Study in Opioid-Induced Constipation in Cancer Patients

> **NCT01189409** · PHASE4 · TERMINATED · sponsor: **British Columbia Cancer Agency** · enrollment: 70 (actual)

## Conditions studied

- Constipation
- Cancer

## Interventions

- **DRUG:** PEG then Senna
- **DRUG:** Senna then PEG

## Key facts

- **NCT ID:** NCT01189409
- **Lead sponsor:** British Columbia Cancer Agency
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2010-06
- **Primary completion:** 2017-12
- **Final completion:** 2018-10
- **Target enrollment:** 70 (ACTUAL)
- **Why stopped:** This study was terminated based on results of interim analysis.
- **Last updated:** 2019-08-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01189409

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01189409, "Polyethylene Glycol (PEG) Versus Sennosides Study in Opioid-Induced Constipation in Cancer Patients". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01189409. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*